Safety and efficacy of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia: A protocol for systematic review and meta-analysis

Safety and efficacy of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia: A protocol for systematic review and meta-analysis

<h3>Introduction</h3><p dir="ltr">Current evidence regarding the efficacy and safety of tyrosine kinase inhibitors in the pediatrics with chronic myeloid leukemia (CML) is limited. The safety of TKI beyond 15years of use has not been studied even in the adult population....

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Fateen Ata (12217764) (author)
مؤلفون آخرون:	Rola S. Ghasoub (21322955) (author), Abdulqadir J. Nashwan (11659453) (author), Kamran Mushtaq (14150814) (author), Mahmood B. Aldapt (11255863) (author), Nancy A. Kassem (21322958) (author), Prem Chandra (9072038) (author), Nabil E. Omar (9545756) (author), Mohamed A. Yassin (8361183) (author)
منشور في:	2022
الموضوعات:	Biomedical and clinical sciences Oncology and carcinogenesis Paediatrics Pharmacology and pharmaceutical sciences chronic myeloid leukemia pediatrics preferred reporting Items for systematic reviews and meta-analyses tyrosine kinase inhibitors
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid Leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors
حسب: Mohamed A. Ismail (418629)
منشور في: (2022)

Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia
حسب: Luisa Tomasello (702932)
منشور في: (2020)

Myelomastocytic transformation in chronic myeloid leukemia blast phase: A case report
حسب: Abdulrahman F. Al-Mashdali (17148316)
منشور في: (2025)

Targeting the MAP Kinase pathway in human acute myeloid leukemia cells using a recombinant anthrax lethal toxin. (c2013)
حسب: Kassab, Elias
منشور في: (2013)

Characterization of the Cytotoxic Mechanism and Mode of Cell Death Induced by a MEK1/2-selective version of Anthrax Lethal Toxin (PrAg/LFW271A) in Acute Myeloid Leukemia
حسب: Mroue, Zeinab
منشور في: (2023)

Dasatinib versus nilotinib as upfront therapy for treatment naïve chronic myeloid leukemia chronic phase
حسب: Mohamed A. Yassin (16322749)
منشور في: (2021)

Targeting human acute myeloid leukemia cells using human recombinant arginase I (Co) - PEG5000 [HuArgl (Co) - PEG5000] - induced arginine depletion. (c2013)
حسب: Tanios, Rita Farid
منشور في: (2013)

The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review
حسب: Maria Benkhadra (19756941)
منشور في: (2024)

Dual Targeting of Matrix Metalloproteases and the MAPK Pathway in Acute Myeloid Leukemia Cells Using an MMP-activated anthrax lethal toxin (PrAgL1/LF)
حسب: Al Saneh, Ahmad
منشور في: (2020)

Characterization of the potency and mechanism of action of a novel dual-selective intermolecularly complemented version of Anthrax Lethal Toxin (PAU2R200A- PAL1I207R/FP59) in Acute myeloid leukemia
حسب: Farhat, Mirna
منشور في: (2023)

Potency and selectivity of a urokinase activated recombinant anthrax toxin to acute myeloid leukemia (AML) cells. (c2015)
حسب: Darwich, Manal El.
منشور في: (2016)

The mechanisms of resistance of anthrax lethal toxin (LeTx)-induced cytotoxicity in AML cells. (c2018)
حسب: Abou Harb, Monica
منشور في: (2018)

Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG
حسب: Giulia Lombardi (3944720)
منشور في: (2022)

Management of chronic myeloid leukaemia: current treatment options, challenges, and future strategies
حسب: Salma Younes (6424865)
منشور في: (2023)

Sensitivity of acute myeloid leukemia cells to the dual targeting of the urokinase plasminogen activator and the MAPK pathway by a urokinase-activated anthrax lethal toxin. (c2013)
حسب: Bekdash, Amira
منشور في: (2013)

Spontaneous tumor lysis syndrome in a patient with accelerated phase chronic myeloid leukemia treated successfully with rasburicase
حسب: Abdulrahman F. Al-Mashdali (17148316)
منشور في: (2022)

In Vitro and In Vivo Effects of Lebanese Cannabis Oil Against Acute Myeloid Leukemia (AML)
حسب: Lteif, Anthony
منشور في: (2023)

Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients
حسب: Mohamed A. Ismail (418629)
منشور في: (2022)

Safety and efficacy of chimeric antigen receptor T-cell therapy for acute myeloid leukemia: A subgroup based meta-analysis
حسب: Mahmoud M. Morsy (18560491)
منشور في: (2024)

The anticancer effect of β-2 himachalen-6-ol from Lebanese wild carrot on human acute myeloid leukemia cells. (c2016)
حسب: Boulos, Joelle C.
منشور في: (2016)

The Anti-Tumor Effect of Flaxseed Lignan Derivatives on Different Acute Myeloid Leukemia Cancer Cells
حسب: Tannous, Stephanie
منشور في: (2020)

Targeting acute myeloid leukemia cells with novel photosensitive ruthenium-based metal-organic compounds. (c2015)
حسب: Azar, Daniel Fadi
منشور في: (2016)

Malva pseudolavatera Leaf Extract Promotes ROS Induction Leading to Apoptosis in Acute Myeloid Leukemia Cells in Vitro
حسب: El Khoury, Marianne
منشور في: (2020)

The vitamin E derivative gamma tocotrienol promotes anti-tumor effects in acute myeloid leukemia cell lines. (c2019)
حسب: Mohamad, Maya Riad
منشور في: (2019)

Anti-neoplastic Effect of Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid on U937 Acute Myeloid Leukemia Cell Line
حسب: Babikian, Patil
منشور في: (2020)

Mechanisms of Cytotoxicity of Wild-Type Anthrax Lethal Toxin (PrAg/LF) to Acute Myeloid Leukemia Cells: The role of Autophagy
حسب: Sarout, Diamo
منشور في: (2024)

Acute Myeloid Leukemia in Qatar (2010–2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes
حسب: Halima El Omri (14778790)
منشور في: (2020)

Mathematical Modeling of Pediatric Leukemia: Logical Modeling Approach
حسب: Lacoste, Valery
منشور في: (2024)

Protein kinase C inhibitor Gö6976 but not Gö6983 induces the reversion of E- to N-cadherin switch and metastatic phenotype in melanoma: identification of the role of protein kinase D1
حسب: Messaouda Merzoug-Larabi (3619421)
منشور في: (2017)

Sensitivity of acute myeloid leukemia cell lines to the dual targeting of the urokinase system and the mapk pathway by modified anthrax toxins. (c2010)
حسب: Timsah, Zahra S.
منشور في: (2010)

Pediatric rhabdomyolysis: a systematic review and meta-analysis of etiologies, management, and outcomes
حسب: Hany A. Zaki (17337673)
منشور في: (2025)

Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients
حسب: Darawan Rinchai (742366)
منشور في: (2021)

Mechanisms of human recombinant arginase I (Co) - PEG5000 [Huarg I (Co) - PEG5000] - induced cytotoxicity on AML cells. (c2017)
حسب: Assaf, Nicole
منشور في: (2017)

Cloning and identification of a novel sugar kinase from Escherichia coli K12. (c2001)
حسب: Hamed, Mayada M.
منشور في: (2001)

FIP1L1- platelet-derived growth factor receptor A -positive chronic eosinophilic leukemia showing dramatic response to imatinib
حسب: Mohammad Abu-Tineh (14829313)
منشور في: (2021)

Efficacy and safety of ibrutinib in central nervous system lymphoma: A systematic review and meta-analysis
حسب: Jaber H. Jaradat (21632849)
منشور في: (2024)

Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
حسب: Iman W. Achkar (4246141)
منشور في: (2018)

Revolutionizing chronic lymphocytic leukemia diagnosis: A deep dive into the diverse applications of machine learning
حسب: Mohamed Elhadary (16329082)
منشور في: (2023)

Dasatinib‐induced chylothorax: An unusual presentation of a common adverse event—A case report with literature review
حسب: Theresa Paul (13140759)
منشور في: (2023)

Myeloid cells in circulation and tumor microenvironment of breast cancer patients
حسب: Salman M. Toor (8854751)
منشور في: (2017)